Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

DMCPA

From Wikipedia, the free encyclopedia
(Redirected from2,5-Dimethoxy-4-methylphenylcyclopropylamine)
Pharmaceutical compound
DMCPA
Clinical data
Other names25D-CPA; 2,5-Dimethoxy-4-methylphenylcyclopropylamine
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Identifiers
  • 2-(2,5-dimethoxy-4-methylphenyl)cyclopropan-1-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC12H17NO2
Molar mass207.273 g·mol−1
3D model (JSmol)
  • O(c1c(cc(OC)c(c1)C2CC2N)C)C
  • InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 checkY
  • Key:HYVPPECPQRBJEQ-UHFFFAOYSA-N checkY
  (verify)

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-knownpsychedelic drug and asubstituted amphetamine andphenylcyclopropylamine.[1]

Use and effects

[edit]

InAlexander Shulgin's bookPiHKAL (Phenethylamines I Have Known and Loved), thedose range is listed as 15 to 20 mg and theduration is listed as 4 to 8 hours.[1] DMCPA producesopen-eye visuals,anorexia, andpsychedelicdreams.[1] One of the reports inPiHKAL gave it a +++ on theShulgin Rating Scale.[1]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

Pharmacology

[edit]

Pharmacodynamics

[edit]

The comprehensivereceptor interactions of DMCPA have been studied.[2]

History

[edit]

DMCPA was first described in thescientific literature by at least 1974.[3]

Society and culture

[edit]

Legal status

[edit]

United Kingdom

[edit]

This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[4]

See also

[edit]

References

[edit]
  1. ^abcdeDMCPA Entry inPiHKAL
  2. ^Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL (July 2025)."The polypharmacology of psychedelics reveals multiple targets for potential therapeutics"(PDF).Neuron.doi:10.1016/j.neuron.2025.06.012.PMID 40683247.
  3. ^Aldous FA, Barrass BC, Brewster K, Buxton DA, Green DM, Pinder RM, Rich P, Skeels M, Tutt KJ (October 1974). "Structure-activity relationships in psychotomimetic phenylalkylamines".J Med Chem.17 (10):1100–1111.doi:10.1021/jm00256a016.PMID 4418757.
  4. ^"UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived fromthe original on 22 October 2017. Retrieved12 March 2014.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=DMCPA&oldid=1323691126"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp